Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:HAV

Helios Advantage Income Fund (HAV) Stock Price, News & Analysis

Helios Advantage Income Fund logo

About Helios Advantage Income Fund Stock (NYSE:HAV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helios Advantage Income Fund and its competitors with MarketBeat's FREE daily newsletter.

HAV Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

HAV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Helios Advantage Income Fund investors own include Clementia Pharmaceuticals (CMTA), JPMorgan Chase & Co. (JPM), Brandywine Realty Trust (BDN), Blueprint Medicines (BPMC), Citrix Systems (CTXS) and CVS Health (CVS).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:HAV
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:HAV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners